⚠️ Disclaimer

Orexin-A is a research compound. It is not approved by the FDA or any regulatory body for human use. This article is for educational and informational purposes only. Nothing here constitutes medical advice. Consult a qualified physician before considering any peptide use.

Orexin-A is Not FDA-approved. Research use only. Development focus has shifted to small molecule receptor agonists. Regulations vary by country, and the legal landscape for peptides is evolving. This guide covers the current legal status and what researchers need to know.

Is Orexin-A Legal?

Not FDA-approved. Research use only. Development focus has shifted to small molecule receptor agonists.

The legal landscape for peptides like Orexin-A is nuanced and varies by jurisdiction. This guide covers the current regulatory status and what researchers need to know.

What Is the Legal Status of Orexin-A in the United States?

Orexin-A is generally available as a research chemical in the US. It is not FDA-approved for human use, which means it cannot be marketed, sold, or prescribed as a drug or supplement.

However, research chemicals can be legally purchased for laboratory, in vitro, or educational use. The key legal distinction is between personal research use and human consumption — the latter is not approved.

Is Orexin-A Legal Internationally?

Peptide regulations vary significantly by country. Some jurisdictions classify peptides as prescription-only compounds, while others allow research chemical sales similar to the US.

Australia: Most peptides require a prescription. UK: Generally available for research. Canada: Research chemical status. EU: Varies by country. Always check local regulations before purchasing.

Is Orexin-A Banned in Sports?

Orexin-A may be subject to anti-doping regulations depending on its class and mechanism. Athletes should check the current WADA prohibited list.

If you compete in any organized sport, assume all peptides are prohibited unless you have confirmed otherwise with your sport's governing body.

How Is the Legal Landscape Changing?

Peptide regulation is an evolving area. The FDA has increased scrutiny of compounding pharmacies and research chemical vendors in recent years. Some peptides that were freely available have faced new restrictions.

Staying informed about regulatory changes is important for researchers working with Orexin-A and similar compounds.

Bottom Line on Orexin-A Legality

Not FDA-approved. Research use only. Development focus has shifted to small molecule receptor agonists. Researchers should ensure compliance with their local laws and use Orexin-A only for legitimate research purposes.

Complete Guide

Orexin-A : Benefits, Dosage, Side Effects & Research

Read the Full Guide →

Related Reading

Calculate Your Orexin-A Dose

Use our free peptide dosing calculator to get exact reconstitution math and syringe units for Orexin-A.

Open Calculator →

Research-Grade Sourcing

If you're going to research Orexin-A, source matters. These are the suppliers WolveStack has vetted for purity and third-party testing.

Limitless → Browse Orexin-A

Frequently Asked Questions

What is Orexin-A?

Orexin-A (Hypocretin-1) is a Neuropeptide hormone. Naturally occurring peptide synthesized in the hypothalamus, regulating sleep-wake cycles and arousal. It is researched for increased wakefulness and arousal, cognitive function in narcolepsy, pain modulation.

What is the recommended Orexin-A dosage?

Common dosages: not established for human peptide administration administered single dose in research protocols via intranasal (experimental human), intracerebroventricular (animal studies). Cycle length: single dose protocols; no established multi-week cycles. Half-life: rapidly degraded peripherally; central CSF half-life estimated 10-30 minutes. Use our peptide calculator for exact reconstitution math.

What are the side effects of Orexin-A?

Limited human safety data. Potential increased heart rate and blood pressure. Poor blood-brain-barrier penetration limits peripheral dosing.

Is Orexin-A safe?

Orexin-A has shown a preliminary safety profile in research. Not FDA-approved. Research use only. Development focus has shifted to small molecule receptor agonists. All research should follow appropriate safety protocols.